Navigation Links
Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007
Date:3/6/2008

the 40-litre level

and investigated further increases in scale to the 100-litre level;

Financial and Intellectual Property

-----------------------------------

- Completed a public offering that added gross proceeds of $13.8 million

to our financial reserves; and,

- Secured an additional eight U.S, patents and one Canadian patent,

bringing our current total to more than 165 patents issued worldwide;

"We expect 2008 to be an outstanding year as we move ahead with our Phase II program and begin to focus our efforts in the clinical program in key indications," said Thompson. "With solid preclinical and Phase I results, a scalable manufacturing process, a comprehensive intellectual property portfolio and the financial resources to support our Phase II program, we are well positioned for an exciting and productive 2008."

Oncolytics Biotech Inc.

BALANCE SHEETS

As at December 31

2007 2006

$ $

-------------------------------------------------------------------------

ASSETS

Current

Cash and cash equivalents 6,715,096 3,491,511

Short-term investments 18,498,733 24,122,237

Accounts receivable 80,085 84,003

Prepaid expenses 260,300 638,540

-------------------------------------------------------------------------

25,554,214 28,336,291

Property and equipment 201,103 149,596

Intellectual property 5,026,540 5,079,805

-------------------------------------------------------------------------'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Media Advisory - Oncolytics Biotech Inc. to Present at Bio CEO & Investor Conference
2. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
3. Oncolytics Biotech Inc. Proceeds to Full Enrolment in U.S. Phase II Sarcoma Clinical Trial
4. Oncolytics Biotech Inc. Announces Issuance of 8th Canadian Patent
5. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Cyclophosphamide Treatment
6. Oncolytics Biotech Inc. Announces Filing of Phase 1/2 Clinical Trial with REOLYSIN(R)
7. Oncolytics Biotech Inc. Completes Patient Enrolment in U.K. Phase Ia/Ib Combination REOLYSIN(R)/Radiation Clinical Trial
8. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
9. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
10. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
11. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Calif. , June 3, 2015 The ... life of myeloma patients while working toward prevention and ... Annual International Myeloma Working Group (IMWG) Summit June 8-10 ... 100-plus IMWG members will attend the 2015 Summit, which ... the European Hematology Association (EHA).  The focus of the ...
(Date:6/3/2015)... 03, 2015 On April 21, 2015, ... and Communications Committee (11-0) and indicates the legislature's desire to ... energy. , The Committee Chairman supports the bill and would ... by 8,000 GWh and would also like to see any ... , This “Wait List” and timing are extremely important. , ...
(Date:6/3/2015)... CHICAGO , June 3, 2015 /PRNewswire/ ... Company"; LSE: CIR), a specialty biopharmaceutical company focused on ... to the Company,s novel immunotherapy candidates targeting house dust ... the 2015 European Academy of Allergy and Clinical Immunology ... on 6-10 June. Sunday, 7 ...
(Date:6/3/2015)... Innovative biomass supply chain industry leader, ... sponsorship of the first annual Advanced Bioeconomy Feedstocks ... Hotel in New Orleans, June 9-10, the conference brings ... to further the advancements of feedstock by discussing pressing ... logistics, yield improvement and more. , As ...
Breaking Biology Technology:International Myeloma Foundation Brings Together 100 of the World's Top Myeloma Experts June 8-10 in Vienna, Austria for 6th Annual Summit 2International Myeloma Foundation Brings Together 100 of the World's Top Myeloma Experts June 8-10 in Vienna, Austria for 6th Annual Summit 3International Myeloma Foundation Brings Together 100 of the World's Top Myeloma Experts June 8-10 in Vienna, Austria for 6th Annual Summit 4Bmark Energy Announces the Sign-up Deadline for Companies Interested in California’s Direct Access Program is June 12th, 2015 at 5:00pm. 2Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 2Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 3Genera to Sponsor Advanced Bioeconomy Feedstocks Conference 2015 2Genera to Sponsor Advanced Bioeconomy Feedstocks Conference 2015 3
... WEST BRIDGEWATER, Mass., Sept. 5 Pressure,BioSciences, Inc. ... has received,approval to CE Mark the Barocycler NEP2320, ... (PCT) instrument. The,Company also announced that it has ... indicating that the Barocycler NEP2320 has been found ...
... CEO of Former Portfolio Company is a Proven Leader ... Genstar Capital, LLC, a middle,market private equity firm that ... healthcare services, industrial technology, business,services and software, today announced ... Advisory Board (SAB). The addition of Mr. Hurt, CEO,of ...
... ,Helps Businesses Find the ... Best ... of,Summit is featured in the September issue of New Jersey Business ... and,Industry Association (NJBIA), the largest state employer organization in,the country. The ...
Cached Biology Technology:Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320 2Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320 3Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320 4Genstar Names Michael Hurt to Its Strategic Advisory Board 2Boyden's Summit Practice Featured in the September Issue of New Jersey Business Magazine 2
(Date:5/22/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... promotional pricing and making the Wocket generally available for $229 ... Head of Marketing said, "We,ve extended the opportunity to take ... May. To get your wocket at this special price, submit ... on June 1, you,ll receive a unique code that gives ...
(Date:5/20/2015)... 2015 Research ... the addition of the  "5-year Opportunity ... Market"  report to their offering.  ,     ... analyses trends in the iris recognition ... sectors, globally. Despite hardware pricing and ...
(Date:5/19/2015)... May 19, 2015 ... the addition of the  "Genetic Testing Market ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic ... analysis of the current and future genetic ... tests, their working principles and types are ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2
... as they are defined in textbooks, are essential ... amounts of energy as they use oxygen. However, ... as Entamoeba histolytica, the causal agent of amoebic ... to support this process. Nevertheless, Entamoeba still contains ...
... student may have figured out why rates of extinction were ... life during one of the greatest ice ages of them ... years ago, late in the Paleozoic Era. , The likely ... this era were singularly equipped to endure severe fluctuations in ...
... new book Hotspots Revisited identifies 34 regions worldwide where ... and amphibians survive within habitat covering just 2.3 percent ... areas of the five largest U.S. states). This habitat ... area equivalent in size to Russia and Australia combined. ...
Cached Biology News:Low level of extinction during ice age linked to adaptability 2Biodiversity hotspots identify conservation priorities 2Biodiversity hotspots identify conservation priorities 3Biodiversity hotspots identify conservation priorities 4Biodiversity hotspots identify conservation priorities 5
Bovine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11:...
DAPI: 4', 6-Diamino-2-phenylindole dihydrochloride. Antifade Solution: p-Phenylenediamine and glycerol in PBS solution. 0.4g/mL DAPI suspended in Antifade....
...
Takara's Mutan-Super Express Km Kit is designed to achieve site-directed mutagenesis in just one day. It is based on Oligonucleotide-directed Dual Amber (ODA) method, using the advantages of LA (Long...
Biology Products: